Literature DB >> 27575742

Etiologies of hemoptysis in children: A systematic review of 171 patients.

Debra R Simon1, Stephen C Aronoff1, Michael T Del Vecchio1.   

Abstract

OBJECTIVE: To provide prevalence rates for the most common causes of hemoptysis in children. DATA SOURCES: A systematic review of articles from PubMed, the OVID Cochrane Reviews (1960-2015), and EMBASE (1991-2015) was undertaken. Additional articles were identified by reviewing the bibliographies of selected studies. Search terms included hemoptysis, children, and humans. STUDY SELECTION: Only case studies and cohorts that examined the causes of hemoptysis in children (birth to 21 years) were included; at least 10 patients were required of each study. DATA EXTRACTION: Inclusion criteria, patient number, age range, patient source, and categorical and specific etiologies of hemoptysis were recorded. DATA SYNTHESIS: From the 1,858 studies identified, seven were selected for inclusion. Eighty-nine percent of participants were found to have a specific etiology for hemoptysis. Of the categorical etiologies identified, infection (37.57%), "other causes" (31.79%), heart disease (6.36%), and neoplasia (4.05%) were the most common. Pneumonia, bronchitis, and pulmonary tuberculosis were the most common specific etiologies identified. LIMITATIONS: By its nature, this study was subject to selection bias and under representation of specific etiologies.
CONCLUSIONS: Most pediatric patients presenting with hemoptysis have a specific etiology; pneumonia is the most common. A thorough history, physical exam, and focused laboratory evaluation is recommended for such patients. Pediatr Pulmonol. 2017;52:255-259.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  children; etiology; hemoptysis; pneumonia; pulmonary disease

Mesh:

Year:  2016        PMID: 27575742     DOI: 10.1002/ppul.23497

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  9 in total

1.  [Clinical effect of endovascular embolization in treatment of hemoptysis of systemic arterial origin in children].

Authors:  Qu-Ming Zhao; Fang Liu; Lin Wu; Lu Zhao; Lan He; Ying Lu; Li-Bo Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

Review 2.  Approach to Hemoptysis in the Modern Era.

Authors:  Sébastien Gagnon; Nicholas Quigley; Hervé Dutau; Antoine Delage; Marc Fortin
Journal:  Can Respir J       Date:  2017-12-21       Impact factor: 2.409

3.  Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients: An Observational Study.

Authors:  Erika R O'Neil; Lindsay R Schmees; Karla Resendiz; Henri Justino; Marc M Anders
Journal:  Crit Care Explor       Date:  2020-01-29

4.  Tranexamic Acid Use for Massive Hemoptysis in a Child: A Case Report.

Authors:  Ahlam Mazi
Journal:  Cureus       Date:  2022-08-19

5.  Pediatric Pulmonary Hemorrhage vs. Extrapulmonary Bleeding in the Differential Diagnosis of Hemoptysis.

Authors:  Michael Vaiman; Baruch Klin; Noa Rosenfeld; Ibrahim Abu-Kishk
Journal:  Cent Asian J Glob Health       Date:  2017-10-23

6.  Foreign body aspiration as a cause of cryptogenic hemoptysis in a child: A case report.

Authors:  Li Qiu; Yiheng Zan; Lin Zhong; Hanmin Liu; Qingfen Tao; Lina Chen
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

Review 7.  Isolated unilateral pulmonary vein atresia with hemoptysis in a child: A case report and literature review.

Authors:  Changqing Tang; Hongyu Duan; Kaiyu Zhou; Yimin Hua; Xiaoliang Liu; Yifei Li; Chuan Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

8.  Inflammatory myofibroblastic lung tumor: its birth, its bleeding growth, its difficult diagnosis and its surgical end in a child.

Authors:  Luca Pecoraro; Maria Clemente; Elisa Tadiotto; Giorgio Piacentini; Angelo Pietrobelli; Daniela Degani
Journal:  Clin Case Rep       Date:  2018-06-06

9.  Unilateral pulmonary vein atresia presenting with recurrent haemoptysis in a child: a case report.

Authors:  Martin Ngie Liong Wong; Ing Ping Tang; Yek Kee Chor; Kiew Siong Lau; Anne Rachel John; King Ching Hii; Olive Pei Yi Lee; Wooi Kok Lim; Hannah Pei Koon Tan
Journal:  BMC Pediatr       Date:  2020-09-24       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.